文献速递关节外科

全关节置换术中关节周围注射的疗效与安全性:一项直接Meta分析

The Efficacy and Safety of Periarticular Injection in Total Joint Arthroplasty: A Direct Meta-Analysis.
PubMed 文献 · J Arthroplasty · 2022-01-01

该直接Meta分析共纳入60项研究,评估初次全关节置换术中关节周围注射(PAI)的疗效与安全性。结果表明,使用长效局部麻醉药的PAI可减少术后疼痛和阿片类药物消耗,加用皮质类固醇和/或酮咯酸可进一步减轻疼痛;吗啡无附加获益且可能增加术后恶心呕吐;脂质体布比卡因与其他长效局麻药无差异;肾上腺素和可乐定证据不足。

要点

  • 长效局部麻醉药PAI可减少全关节置换术后疼痛和阿片类药物消耗。
  • 在长效局麻药中加入皮质类固醇和/或酮咯酸可进一步减轻术后疼痛。
  • 吗啡无附加获益且可能增加术后恶心呕吐,肾上腺素和可乐定证据不足。

核心结论

  • 强证据支持使用含长效局部麻醉药的关节周围注射以减少术后疼痛和阿片类药物消耗。
  • 在长效局麻药中加入皮质类固醇和/或酮咯酸可进一步减轻术后疼痛,并可能减少阿片类药物消耗。
  • 吗啡无附加效应,肾上腺素和可乐定的证据不足。

研究设计与样本

  • 检索MEDLINE、Embase和Cochrane Central Register of Controlled Trials数据库中2020年3月前发表的关于全关节置换术中关节周围注射的研究。
  • 所有纳入研究经定性和定量同质性检验后行系统综述和直接比较Meta分析,以评估PAI的疗效和安全性。

主要发现

  • Meta分析显示术中PAI可减少术后疼痛和阿片类药物消耗。
  • 在长效局麻药(如罗哌卡因或布比卡因)中加入酮咯酸或皮质类固醇可提供额外获益。
  • 脂质体布比卡因与其他非脂质体长效局麻药之间无差异。
  • 吗啡对术后疼痛和阿片类药物消耗无任何附加获益,且可能增加术后恶心呕吐。
  • 关于肾上腺素和可乐定使用的证据不足以得出结论。

临床怎么用

  • 作者结论支持使用含长效局部麻醉药的PAI以减少术后疼痛和阿片类药物消耗。
  • 作者认为在长效局麻药中加入皮质类固醇和/或酮咯酸可进一步减轻术后疼痛并可能减少阿片类药物消耗。
  • 作者指出吗啡无附加效应,肾上腺素和可乐定证据不足。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Periarticular injection (PAI) is administered intraoperatively to help reduce postoperative pain and opioid consumption after primary total joint arthroplasty (TJA). The purpose of this study was to evaluate the efficacy and safety of PAI in primary TJA to support the combined clinical practice guidelines of the American Association of Hip and Knee Surgeons, American Academy of Orthopaedic Surgeons, Hip Society, Knee Society, and American Society of Regional Anesthesia and Pain Medicine. METHODS: The MEDLINE, Embase, and Cochrane Central Register of Controlled Trials databases were searched for studies published prior to March 2020 on PAI in TJA. All included studies underwent qualitative and quantitative homogeneity testing followed by a systematic review and direct comparison meta-analysis to assess the efficacy and safety of PAI. RESULTS: Three thousand six hundred and ninety nine publications were critically appraised to provide 60 studies regarded as the best available evidence for an analysis. The meta-analysis showed that intraoperative PAI reduces postoperative pain and opioid consumption. Adding ketorolac or a corticosteroid to a long-acting local anesthetic (eg, ropivacaine or bupivacaine) provides an additional benefit. There is no difference between liposomal bupivacaine and other nonliposomal long-acting local anesthetics. Morphine does not provide any additive benefit in postoperative pain and opioid consumption and may increase postoperative nausea and vomiting. There is insufficient evidence to draw conclusions on the use of epinephrine and clonidine. CONCLUSION: Strong evidence supports the use of a PAI with a long-acting local anesthetic to reduce postoperative pain and opioid consumption. Adding a corticosteroid and/or ketorolac to a long-acting local anesthetic further reduces postoperative pain and may reduce opioid consumption. Morphine has no additive effect and there is insufficient evidence on epinephrine and clonidine.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Hannon CP, Fillingham YA, Spangehl MJ, et al. The Efficacy and Safety of Periarticular Injection in Total Joint Arthroplasty: A Direct Meta-Analysis. J Arthroplasty. 2022. PMID: 36162925. doi:10.1016/j.arth.2022.03.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。